- Home
- RDZN vs TKNO Comparison
RDZN vs TKNO Comparison
Compare RDZN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RDZN | TKNO |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.7M | 138.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | RDZN | TKNO |
|---|---|---|
| Price | $1.18 | $3.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 84.5K | ★ 116.4K |
| Earning Date | 02-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $33.77 | $8.27 |
| Revenue Next Year | $51.46 | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $0.68 | $1.91 |
| 52 Week High | $2.56 | $7.48 |
Technical Indicators
Market Signals| Indicator | RDZN | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 58.42 |
| Support Level | $1.12 | $3.01 |
| Resistance Level | $1.21 | $3.25 |
| Average True Range (ATR) | 0.08 | 0.25 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 50.00 | 79.29 |
Price Performance
Historical ComparisonAbout RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.